A Phase 2b Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel Group, Dose Range Finding Study of JNJ-38518168 in Subjects With Active Rheumatoid Arthritis Despite Concomitant Methotrexate Therapy
Phase of Trial: Phase II
Latest Information Update: 29 Mar 2017
At a glance
- Drugs Toreforant (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 07 Jun 2017 Biomarkers information updated
- 01 Jul 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
- 06 Feb 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.